Health Care & Life Sciences » Pharmaceuticals | Hanmi Pharmaceutical Co. Ltd.

Hanmi Pharmaceutical Co. Ltd. | Ownership

Companies that own Hanmi Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
National Pension Service of Korea
1,143,056
10.03%
4,985
0.39%
06/29/2018
The Vanguard Group, Inc.
171,416
1.51%
1,547
0%
07/31/2018
BlackRock Fund Advisors
144,358
1.27%
0
0%
09/06/2018
Mirae Asset Global Investments Co., Ltd.
65,134
0.56%
-844
0.24%
04/30/2018
Norges Bank Investment Management
63,297
0.56%
-69,203
0%
12/31/2017
TOBAM SAS
52,459
0.46%
3,404
0.41%
09/06/2018
BlackRock Advisors (UK) Ltd.
41,296
0.36%
0
0.01%
09/06/2018
Dimensional Fund Advisors LP
32,737
0.28%
-11,228
0%
04/30/2018
TIAA-CREF Investment Management LLC
20,510
0.18%
0
0.01%
03/31/2018
Invesco Hong Kong Ltd.
11,000
0.1%
-2,770
0.09%
03/29/2018

About Hanmi Pharmaceutical Co.

View Profile
Address
214 Muha-ro
Hwaseong GY 18536
Korea, Republic Of
Employees -
Website http://www.hanmipharm.com
Updated 07/08/2019
Hanmi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for high blood pressure, hyperlipidemia, reflux esophagitis, and cerebrovascular disease. The company was founded by Lim Sung-Gi on June 15, 1973 and is headquartered in Hwaseong-si, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.